Zhong Zhao

FDA investigator

Appears on 3 documents from 2022 to 2023, mostly at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

3
Documents on file
6.7
Observations per 483
2022
First seen
2023
Most recent

What they cite most

From 20 observations

Activity by year

2022: 1, 2023: 2

Where

India 2 · South Korea 1

Is Zhong Zhao coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Dr. Reddy's Laboratories, Ltd.Oct 12, 2023 · Hyderabad, India
483 DR.REDDY'S LABORATORIES LIMITEDOct 12, 2023 · Bachupally Village, India
483 Hanmi Pharm. Co., Ltd.Jul 5, 2022 · Pyeongtaek, South Korea

About this profile

What does Zhong Zhao inspect?

Zhong Zhao appears on 3 documents on file covering 2 sites, mostly in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Zhong Zhao is dated Oct 12, 2023.